nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—ADRA2A—type 2 diabetes mellitus	0.106	0.299	CbGaD
Thioridazine—HTR2C—type 2 diabetes mellitus	0.0973	0.275	CbGaD
Thioridazine—CYP2E1—type 2 diabetes mellitus	0.0772	0.218	CbGaD
Thioridazine—CYP1A2—type 2 diabetes mellitus	0.0734	0.208	CbGaD
Thioridazine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0311	0.071	CbGbCtD
Thioridazine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0273	0.0622	CbGbCtD
Thioridazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0217	0.0494	CbGbCtD
Thioridazine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0174	0.0396	CbGbCtD
Thioridazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0159	0.0362	CbGbCtD
Thioridazine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.015	0.0342	CbGbCtD
Thioridazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.015	0.0341	CbGbCtD
Thioridazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0143	0.0326	CbGbCtD
Thioridazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0143	0.0326	CbGbCtD
Thioridazine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0137	0.0313	CbGbCtD
Thioridazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0132	0.0301	CbGbCtD
Thioridazine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.012	0.0274	CbGbCtD
Thioridazine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0109	0.0248	CbGbCtD
Thioridazine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0107	0.0244	CbGbCtD
Thioridazine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0105	0.0239	CbGbCtD
Thioridazine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.01	0.0228	CbGbCtD
Thioridazine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00968	0.0221	CbGbCtD
Thioridazine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00958	0.0218	CbGbCtD
Thioridazine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00911	0.0208	CbGbCtD
Thioridazine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00911	0.0208	CbGbCtD
Thioridazine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00891	0.0203	CbGbCtD
Thioridazine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00841	0.0192	CbGbCtD
Thioridazine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00812	0.0185	CbGbCtD
Thioridazine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00789	0.018	CbGbCtD
Thioridazine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00776	0.0177	CbGbCtD
Thioridazine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00757	0.0173	CbGbCtD
Thioridazine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00757	0.0173	CbGbCtD
Thioridazine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00699	0.0159	CbGbCtD
Thioridazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00693	0.0158	CbGbCtD
Thioridazine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00675	0.0154	CbGbCtD
Thioridazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00639	0.0146	CbGbCtD
Thioridazine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00617	0.0141	CbGbCtD
Thioridazine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00611	0.0139	CbGbCtD
Thioridazine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00578	0.0132	CbGbCtD
Thioridazine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00574	0.0131	CbGbCtD
Thioridazine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0055	0.0125	CbGbCtD
Thioridazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00525	0.012	CbGbCtD
Thioridazine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00508	0.0116	CbGbCtD
Thioridazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00503	0.0115	CbGbCtD
Thioridazine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00466	0.0106	CbGbCtD
Thioridazine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00427	0.00972	CbGbCtD
Thioridazine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00394	0.00897	CbGbCtD
Thioridazine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00388	0.00884	CbGbCtD
Thioridazine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00355	0.00809	CbGbCtD
Thioridazine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00215	0.0874	CbGeAlD
Thioridazine—HTR2A—arteriole—type 2 diabetes mellitus	0.0021	0.0856	CbGeAlD
Thioridazine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00144	0.0588	CbGeAlD
Thioridazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00134	0.0545	CbGeAlD
Thioridazine—DRD1—nerve—type 2 diabetes mellitus	0.0013	0.0529	CbGeAlD
Thioridazine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00104	0.0424	CbGeAlD
Thioridazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.0009	0.0366	CbGeAlD
Thioridazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000833	0.0339	CbGeAlD
Thioridazine—HTR7—artery—type 2 diabetes mellitus	0.000818	0.0333	CbGeAlD
Thioridazine—HTR7—nerve—type 2 diabetes mellitus	0.000812	0.0331	CbGeAlD
Thioridazine—DRD2—nerve—type 2 diabetes mellitus	0.000768	0.0313	CbGeAlD
Thioridazine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000764	0.0311	CbGeAlD
Thioridazine—HTR7—endothelium—type 2 diabetes mellitus	0.000691	0.0281	CbGeAlD
Thioridazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000649	0.0264	CbGeAlD
Thioridazine—HTR2A—artery—type 2 diabetes mellitus	0.00051	0.0208	CbGeAlD
Thioridazine—HTR2A—nerve—type 2 diabetes mellitus	0.000506	0.0206	CbGeAlD
Thioridazine—ADRA1B—kidney—type 2 diabetes mellitus	0.000478	0.0195	CbGeAlD
Thioridazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000431	0.0176	CbGeAlD
Thioridazine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000367	0.0149	CbGeAlD
Thioridazine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000366	0.0149	CbGeAlD
Thioridazine—DRD2—retina—type 2 diabetes mellitus	0.000318	0.0129	CbGeAlD
Thioridazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000298	0.0121	CbGeAlD
Thioridazine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000288	0.0117	CbGeAlD
Thioridazine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000284	0.0116	CbGeAlD
Thioridazine—HTR7—kidney—type 2 diabetes mellitus	0.000278	0.0113	CbGeAlD
Thioridazine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000274	0.0112	CbGeAlD
Thioridazine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000265	0.0108	CbGeAlD
Thioridazine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000242	0.00985	CbGeAlD
Thioridazine—CYP2C8—kidney—type 2 diabetes mellitus	0.000237	0.00966	CbGeAlD
Thioridazine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000227	0.00925	CbGeAlD
Thioridazine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000215	0.00877	CbGeAlD
Thioridazine—HTR2A—retina—type 2 diabetes mellitus	0.00021	0.00854	CbGeAlD
Thioridazine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000204	0.00831	CbGeAlD
Thioridazine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000203	0.00825	CbGeAlD
Thioridazine—CYP2E1—kidney—type 2 diabetes mellitus	0.0002	0.00813	CbGeAlD
Thioridazine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000199	0.00809	CbGeAlD
Thioridazine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000194	0.00792	CbGeAlD
Thioridazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000187	0.00762	CbGeAlD
Thioridazine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000184	0.00749	CbGeAlD
Thioridazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000177	0.00722	CbGeAlD
Thioridazine—HTR7—liver—type 2 diabetes mellitus	0.000176	0.00716	CbGeAlD
Thioridazine—HTR2A—kidney—type 2 diabetes mellitus	0.000174	0.00707	CbGeAlD
Thioridazine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000173	0.0017	CcSEcCtD
Thioridazine—CYP2C19—liver—type 2 diabetes mellitus	0.000172	0.00699	CbGeAlD
Thioridazine—Angioedema—Glyburide—type 2 diabetes mellitus	0.000171	0.00169	CcSEcCtD
Thioridazine—Nausea—Acarbose—type 2 diabetes mellitus	0.000171	0.00169	CcSEcCtD
Thioridazine—Constipation—Glipizide—type 2 diabetes mellitus	0.00017	0.00168	CcSEcCtD
Thioridazine—ADRA1A—liver—type 2 diabetes mellitus	0.00017	0.00691	CbGeAlD
Thioridazine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000169	0.00167	CcSEcCtD
Thioridazine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00167	CcSEcCtD
Thioridazine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000168	0.00166	CcSEcCtD
Thioridazine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000168	0.00166	CcSEcCtD
Thioridazine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00165	CcSEcCtD
Thioridazine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000166	0.00164	CcSEcCtD
Thioridazine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000165	0.00163	CcSEcCtD
Thioridazine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000165	0.00163	CcSEcCtD
Thioridazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00162	CcSEcCtD
Thioridazine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000164	0.00162	CcSEcCtD
Thioridazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000164	0.00162	CcSEcCtD
Thioridazine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000164	0.00162	CcSEcCtD
Thioridazine—Weight increased—Losartan—type 2 diabetes mellitus	0.000163	0.00161	CcSEcCtD
Thioridazine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00161	CcSEcCtD
Thioridazine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000161	0.00159	CcSEcCtD
Thioridazine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00159	CcSEcCtD
Thioridazine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00157	CcSEcCtD
Thioridazine—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000159	0.00157	CcSEcCtD
Thioridazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000159	0.00157	CcSEcCtD
Thioridazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00156	CcSEcCtD
Thioridazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000158	0.00644	CbGeAlD
Thioridazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000158	0.00156	CcSEcCtD
Thioridazine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000157	0.00155	CcSEcCtD
Thioridazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00154	CcSEcCtD
Thioridazine—Jaundice—Losartan—type 2 diabetes mellitus	0.000156	0.00154	CcSEcCtD
Thioridazine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000156	0.00154	CcSEcCtD
Thioridazine—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000156	0.00154	CcSEcCtD
Thioridazine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000155	0.00153	CcSEcCtD
Thioridazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000155	0.00153	CcSEcCtD
Thioridazine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000154	0.00152	CcSEcCtD
Thioridazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000154	0.00152	CcSEcCtD
Thioridazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000154	0.00152	CcSEcCtD
Thioridazine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000154	0.00152	CcSEcCtD
Thioridazine—Oedema—Glyburide—type 2 diabetes mellitus	0.000153	0.00151	CcSEcCtD
Thioridazine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000153	0.00151	CcSEcCtD
Thioridazine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000153	0.00151	CcSEcCtD
Thioridazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000152	0.0015	CcSEcCtD
Thioridazine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000152	0.0015	CcSEcCtD
Thioridazine—Rash—Repaglinide—type 2 diabetes mellitus	0.000151	0.00149	CcSEcCtD
Thioridazine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000151	0.00149	CcSEcCtD
Thioridazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000151	0.00149	CcSEcCtD
Thioridazine—Headache—Repaglinide—type 2 diabetes mellitus	0.000151	0.00149	CcSEcCtD
Thioridazine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.00015	0.00148	CcSEcCtD
Thioridazine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.00015	0.00148	CcSEcCtD
Thioridazine—CYP2C8—liver—type 2 diabetes mellitus	0.00015	0.0061	CbGeAlD
Thioridazine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00015	0.00148	CcSEcCtD
Thioridazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000149	0.00147	CcSEcCtD
Thioridazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00147	CcSEcCtD
Thioridazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000149	0.0474	CrCbGaD
Thioridazine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000148	0.00146	CcSEcCtD
Thioridazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000146	0.00145	CcSEcCtD
Thioridazine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000146	0.00144	CcSEcCtD
Thioridazine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000146	0.00144	CcSEcCtD
Thioridazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000146	0.00144	CcSEcCtD
Thioridazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00144	CcSEcCtD
Thioridazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000144	0.00142	CcSEcCtD
Thioridazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000143	0.00141	CcSEcCtD
Thioridazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00141	CcSEcCtD
Thioridazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000143	0.00141	CcSEcCtD
Thioridazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000143	0.00141	CcSEcCtD
Thioridazine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000143	0.00141	CcSEcCtD
Thioridazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000142	0.0014	CcSEcCtD
Thioridazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000141	0.00139	CcSEcCtD
Thioridazine—Erythema—Metformin—type 2 diabetes mellitus	0.000141	0.00139	CcSEcCtD
Thioridazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Thioridazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00014	0.00138	CcSEcCtD
Thioridazine—CYP1A2—liver—type 2 diabetes mellitus	0.00014	0.00571	CbGeAlD
Thioridazine—Weight increased—Ramipril—type 2 diabetes mellitus	0.00014	0.00138	CcSEcCtD
Thioridazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.00014	0.00138	CcSEcCtD
Thioridazine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000139	0.00137	CcSEcCtD
Thioridazine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00136	CcSEcCtD
Thioridazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000137	0.00135	CcSEcCtD
Thioridazine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Thioridazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00134	CcSEcCtD
Thioridazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000136	0.00134	CcSEcCtD
Thioridazine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000135	0.00133	CcSEcCtD
Thioridazine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000135	0.00133	CcSEcCtD
Thioridazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000134	0.00132	CcSEcCtD
Thioridazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000134	0.00132	CcSEcCtD
Thioridazine—CYP2C9—liver—type 2 diabetes mellitus	0.000133	0.00542	CbGeAlD
Thioridazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000133	0.00131	CcSEcCtD
Thioridazine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000133	0.00131	CcSEcCtD
Thioridazine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000133	0.00131	CcSEcCtD
Thioridazine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000133	0.00131	CcSEcCtD
Thioridazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Thioridazine—Tremor—Metformin—type 2 diabetes mellitus	0.000132	0.0013	CcSEcCtD
Thioridazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Thioridazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Thioridazine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Thioridazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000128	0.00126	CcSEcCtD
Thioridazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000127	0.00125	CcSEcCtD
Thioridazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000127	0.00125	CcSEcCtD
Thioridazine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000126	0.00125	CcSEcCtD
Thioridazine—Oedema—Valsartan—type 2 diabetes mellitus	0.000126	0.00125	CcSEcCtD
Thioridazine—CYP2E1—liver—type 2 diabetes mellitus	0.000126	0.00514	CbGeAlD
Thioridazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000126	0.0402	CrCbGaD
Thioridazine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000126	0.00124	CcSEcCtD
Thioridazine—Rash—Glipizide—type 2 diabetes mellitus	0.000125	0.00124	CcSEcCtD
Thioridazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000125	0.00124	CcSEcCtD
Thioridazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000125	0.00124	CcSEcCtD
Thioridazine—Erythema—Losartan—type 2 diabetes mellitus	0.000125	0.00123	CcSEcCtD
Thioridazine—Oedema—Orlistat—type 2 diabetes mellitus	0.000125	0.00123	CcSEcCtD
Thioridazine—Headache—Glipizide—type 2 diabetes mellitus	0.000125	0.00123	CcSEcCtD
Thioridazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000125	0.00123	CcSEcCtD
Thioridazine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000124	0.00122	CcSEcCtD
Thioridazine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000123	0.00121	CcSEcCtD
Thioridazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Thioridazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Thioridazine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Thioridazine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Thioridazine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000121	0.00119	CcSEcCtD
Thioridazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000121	0.0384	CrCbGaD
Thioridazine—Anorexia—Valsartan—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Thioridazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Thioridazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000119	0.00117	CcSEcCtD
Thioridazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000119	0.0379	CrCbGaD
Thioridazine—Nausea—Glipizide—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Thioridazine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000118	0.00116	CcSEcCtD
Thioridazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000118	0.00116	CcSEcCtD
Thioridazine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000118	0.00116	CcSEcCtD
Thioridazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000118	0.0375	CrCbGaD
Thioridazine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00116	CcSEcCtD
Thioridazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Thioridazine—Tremor—Losartan—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Thioridazine—Rash—Glimepiride—type 2 diabetes mellitus	0.000117	0.00115	CcSEcCtD
Thioridazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000117	0.00115	CcSEcCtD
Thioridazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000117	0.00115	CcSEcCtD
Thioridazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Thioridazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Thioridazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000116	0.037	CrCbGaD
Thioridazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00114	CcSEcCtD
Thioridazine—Anaemia—Losartan—type 2 diabetes mellitus	0.000116	0.00114	CcSEcCtD
Thioridazine—Agitation—Losartan—type 2 diabetes mellitus	0.000115	0.00113	CcSEcCtD
Thioridazine—Oedema—Metformin—type 2 diabetes mellitus	0.000115	0.00113	CcSEcCtD
Thioridazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00113	CcSEcCtD
Thioridazine—Angioedema—Losartan—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Thioridazine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Thioridazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000113	0.00111	CcSEcCtD
Thioridazine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000113	0.00111	CcSEcCtD
Thioridazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000112	0.00111	CcSEcCtD
Thioridazine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000112	0.0011	CcSEcCtD
Thioridazine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Thioridazine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Thioridazine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Thioridazine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00108	CcSEcCtD
Thioridazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00011	0.00108	CcSEcCtD
Thioridazine—HTR2A—liver—type 2 diabetes mellitus	0.00011	0.00447	CbGeAlD
Thioridazine—Anorexia—Metformin—type 2 diabetes mellitus	0.00011	0.00108	CcSEcCtD
Thioridazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000109	0.00107	CcSEcCtD
Thioridazine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Thioridazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Thioridazine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Thioridazine—Constipation—Valsartan—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Thioridazine—Metixene—HTR2C—type 2 diabetes mellitus	0.000108	0.0344	CrCbGaD
Thioridazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Thioridazine—Erythema—Ramipril—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Thioridazine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Thioridazine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Thioridazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000106	0.00104	CcSEcCtD
Thioridazine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00104	CcSEcCtD
Thioridazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Thioridazine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000105	0.00103	CcSEcCtD
Thioridazine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00103	CcSEcCtD
Thioridazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000105	0.00103	CcSEcCtD
Thioridazine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Thioridazine—Confusional state—Losartan—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Thioridazine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000103	0.00101	CcSEcCtD
Thioridazine—Somnolence—Metformin—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Thioridazine—Oedema—Losartan—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Thioridazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000101	0.001	CcSEcCtD
Thioridazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000101	0.000999	CcSEcCtD
Thioridazine—Tremor—Ramipril—type 2 diabetes mellitus	0.0001	0.000992	CcSEcCtD
Thioridazine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.99e-05	0.000986	CcSEcCtD
Thioridazine—CYP2D6—liver—type 2 diabetes mellitus	9.99e-05	0.00407	CbGeAlD
Thioridazine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.99e-05	0.000986	CcSEcCtD
Thioridazine—Tachycardia—Losartan—type 2 diabetes mellitus	9.96e-05	0.000983	CcSEcCtD
Thioridazine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.94e-05	0.000981	CcSEcCtD
Thioridazine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.87e-05	0.000974	CcSEcCtD
Thioridazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.86e-05	0.000973	CcSEcCtD
Thioridazine—Agitation—Ramipril—type 2 diabetes mellitus	9.86e-05	0.000973	CcSEcCtD
Thioridazine—Constipation—Metformin—type 2 diabetes mellitus	9.83e-05	0.00097	CcSEcCtD
Thioridazine—Angioedema—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000967	CcSEcCtD
Thioridazine—Anorexia—Losartan—type 2 diabetes mellitus	9.73e-05	0.00096	CcSEcCtD
Thioridazine—Vomiting—Glyburide—type 2 diabetes mellitus	9.73e-05	0.00096	CcSEcCtD
Thioridazine—Rash—Glyburide—type 2 diabetes mellitus	9.65e-05	0.000952	CcSEcCtD
Thioridazine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000952	CcSEcCtD
Thioridazine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.64e-05	0.000951	CcSEcCtD
Thioridazine—Leukopenia—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000947	CcSEcCtD
Thioridazine—Headache—Glyburide—type 2 diabetes mellitus	9.58e-05	0.000946	CcSEcCtD
Thioridazine—Hypotension—Losartan—type 2 diabetes mellitus	9.54e-05	0.000941	CcSEcCtD
Thioridazine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.47e-05	0.000935	CcSEcCtD
Thioridazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.00093	CcSEcCtD
Thioridazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000928	CcSEcCtD
Thioridazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	9.33e-05	0.0298	CrCbGaD
Thioridazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.3e-05	0.000918	CcSEcCtD
Thioridazine—Constipation—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000915	CcSEcCtD
Thioridazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.19e-05	0.000907	CcSEcCtD
Thioridazine—Nausea—Glyburide—type 2 diabetes mellitus	9.09e-05	0.000897	CcSEcCtD
Thioridazine—Somnolence—Losartan—type 2 diabetes mellitus	9.07e-05	0.000895	CcSEcCtD
Thioridazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	9.04e-05	0.0288	CrCbGaD
Thioridazine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000882	CcSEcCtD
Thioridazine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.87e-05	0.000876	CcSEcCtD
Thioridazine—Confusional state—Ramipril—type 2 diabetes mellitus	8.83e-05	0.000871	CcSEcCtD
Thioridazine—Oedema—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000864	CcSEcCtD
Thioridazine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.73e-05	0.000862	CcSEcCtD
Thioridazine—Constipation—Losartan—type 2 diabetes mellitus	8.73e-05	0.000861	CcSEcCtD
Thioridazine—Rash—Gliclazide—type 2 diabetes mellitus	8.66e-05	0.000855	CcSEcCtD
Thioridazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.65e-05	0.000854	CcSEcCtD
Thioridazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.64e-05	0.000852	CcSEcCtD
Thioridazine—Headache—Gliclazide—type 2 diabetes mellitus	8.61e-05	0.000849	CcSEcCtD
Thioridazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000846	CcSEcCtD
Thioridazine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000846	CcSEcCtD
Thioridazine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000843	CcSEcCtD
Thioridazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.53e-05	0.000842	CcSEcCtD
Thioridazine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000835	CcSEcCtD
Thioridazine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.41e-05	0.00083	CcSEcCtD
Thioridazine—Anorexia—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000823	CcSEcCtD
Thioridazine—Hypotension—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000807	CcSEcCtD
Thioridazine—Nausea—Gliclazide—type 2 diabetes mellitus	8.16e-05	0.000805	CcSEcCtD
Thioridazine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.07e-05	0.000796	CcSEcCtD
Thioridazine—Vomiting—Valsartan—type 2 diabetes mellitus	8.03e-05	0.000792	CcSEcCtD
Thioridazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000789	CcSEcCtD
Thioridazine—Rash—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000785	CcSEcCtD
Thioridazine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.95e-05	0.000785	CcSEcCtD
Thioridazine—Vomiting—Orlistat—type 2 diabetes mellitus	7.93e-05	0.000782	CcSEcCtD
Thioridazine—Headache—Valsartan—type 2 diabetes mellitus	7.91e-05	0.00078	CcSEcCtD
Thioridazine—Clemastine—CYP3A4—type 2 diabetes mellitus	7.87e-05	0.0251	CrCbGaD
Thioridazine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.86e-05	0.000776	CcSEcCtD
Thioridazine—Rash—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000776	CcSEcCtD
Thioridazine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000775	CcSEcCtD
Thioridazine—Headache—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000771	CcSEcCtD
Thioridazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	7.79e-05	0.0248	CrCbGaD
Thioridazine—Somnolence—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000768	CcSEcCtD
Thioridazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000751	CcSEcCtD
Thioridazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.52e-05	0.000742	CcSEcCtD
Thioridazine—Nausea—Valsartan—type 2 diabetes mellitus	7.5e-05	0.00074	CcSEcCtD
Thioridazine—Constipation—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000739	CcSEcCtD
Thioridazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000732	CcSEcCtD
Thioridazine—Nausea—Orlistat—type 2 diabetes mellitus	7.41e-05	0.000731	CcSEcCtD
Thioridazine—Vomiting—Metformin—type 2 diabetes mellitus	7.31e-05	0.000721	CcSEcCtD
Thioridazine—Rash—Metformin—type 2 diabetes mellitus	7.25e-05	0.000715	CcSEcCtD
Thioridazine—Dermatitis—Metformin—type 2 diabetes mellitus	7.24e-05	0.000714	CcSEcCtD
Thioridazine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000712	CcSEcCtD
Thioridazine—Headache—Metformin—type 2 diabetes mellitus	7.2e-05	0.000711	CcSEcCtD
Thioridazine—Thiothixene—HTR2C—type 2 diabetes mellitus	7.17e-05	0.0229	CrCbGaD
Thioridazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	7.08e-05	0.0226	CrCbGaD
Thioridazine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.98e-05	0.000689	CcSEcCtD
Thioridazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000683	CcSEcCtD
Thioridazine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000681	CcSEcCtD
Thioridazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	6.85e-05	0.0219	CrCbGaD
Thioridazine—Rash—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000675	CcSEcCtD
Thioridazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000674	CcSEcCtD
Thioridazine—Nausea—Metformin—type 2 diabetes mellitus	6.83e-05	0.000674	CcSEcCtD
Thioridazine—Headache—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000671	CcSEcCtD
Thioridazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	6.73e-05	0.0215	CrCbGaD
Thioridazine—Vomiting—Losartan—type 2 diabetes mellitus	6.49e-05	0.00064	CcSEcCtD
Thioridazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000636	CcSEcCtD
Thioridazine—Nausea—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000636	CcSEcCtD
Thioridazine—Rash—Losartan—type 2 diabetes mellitus	6.44e-05	0.000635	CcSEcCtD
Thioridazine—Dermatitis—Losartan—type 2 diabetes mellitus	6.43e-05	0.000635	CcSEcCtD
Thioridazine—Headache—Losartan—type 2 diabetes mellitus	6.39e-05	0.000631	CcSEcCtD
Thioridazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	6.2e-05	0.0198	CrCbGaD
Thioridazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	6.16e-05	0.0196	CrCbGaD
Thioridazine—Nausea—Losartan—type 2 diabetes mellitus	6.06e-05	0.000598	CcSEcCtD
Thioridazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000591	CcSEcCtD
Thioridazine—Propiomazine—HTR2C—type 2 diabetes mellitus	5.96e-05	0.019	CrCbGaD
Thioridazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	5.85e-05	0.0187	CrCbGaD
Thioridazine—Clomipramine—HTR2C—type 2 diabetes mellitus	5.67e-05	0.0181	CrCbGaD
Thioridazine—Vomiting—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000549	CcSEcCtD
Thioridazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	5.54e-05	0.0177	CrCbGaD
Thioridazine—Rash—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000545	CcSEcCtD
Thioridazine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000544	CcSEcCtD
Thioridazine—Headache—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000541	CcSEcCtD
Thioridazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	5.41e-05	0.0173	CrCbGaD
Thioridazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	5.41e-05	0.0173	CrCbGaD
Thioridazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	5.32e-05	0.017	CrCbGaD
Thioridazine—Eletriptan—CYP3A4—type 2 diabetes mellitus	5.31e-05	0.0169	CrCbGaD
Thioridazine—Nausea—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000513	CcSEcCtD
Thioridazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	5.1e-05	0.0163	CrCbGaD
Thioridazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	5.04e-05	0.0161	CrCbGaD
Thioridazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	4.95e-05	0.0158	CrCbGaD
Thioridazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	4.92e-05	0.0157	CrCbGaD
Thioridazine—Perphenazine—HTR2C—type 2 diabetes mellitus	4.9e-05	0.0156	CrCbGaD
Thioridazine—Promazine—ADRA2A—type 2 diabetes mellitus	4.8e-05	0.0153	CrCbGaD
Thioridazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	4.68e-05	0.0149	CrCbGaD
Thioridazine—Promazine—HTR2C—type 2 diabetes mellitus	4.42e-05	0.0141	CrCbGaD
Thioridazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	4.28e-05	0.0136	CrCbGaD
Thioridazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	4.22e-05	0.0135	CrCbGaD
Thioridazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	4.04e-05	0.0129	CrCbGaD
Thioridazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	3.89e-05	0.0124	CrCbGaD
Thioridazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	3.85e-05	0.0123	CrCbGaD
Thioridazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	3.74e-05	0.0119	CrCbGaD
Thioridazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	3.7e-05	0.0118	CrCbGaD
Thioridazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	3.58e-05	0.0114	CrCbGaD
Thioridazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	3.42e-05	0.0109	CrCbGaD
Thioridazine—Promazine—CYP1A2—type 2 diabetes mellitus	3.33e-05	0.0106	CrCbGaD
Thioridazine—Acepromazine—ALB—type 2 diabetes mellitus	3.25e-05	0.0104	CrCbGaD
Thioridazine—Thioproperazine—ALB—type 2 diabetes mellitus	3.18e-05	0.0101	CrCbGaD
Thioridazine—Pipotiazine—ALB—type 2 diabetes mellitus	3.12e-05	0.00997	CrCbGaD
Thioridazine—Thiothixene—ALB—type 2 diabetes mellitus	3.12e-05	0.00997	CrCbGaD
Thioridazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	3.08e-05	0.00984	CrCbGaD
Thioridazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.93e-05	0.00936	CrCbGaD
Thioridazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.83e-05	0.00903	CrCbGaD
Thioridazine—Clomipramine—ALB—type 2 diabetes mellitus	2.47e-05	0.00788	CrCbGaD
Thioridazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	2.45e-05	0.00781	CrCbGaD
Thioridazine—Promazine—CYP3A4—type 2 diabetes mellitus	2.21e-05	0.00704	CrCbGaD
Thioridazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.94e-05	0.0062	CrCbGaD
Thioridazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.69e-05	0.0054	CrCbGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.8e-06	2.28e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.79e-06	2.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.79e-06	2.27e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.79e-06	2.27e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.78e-06	2.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	2.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	2.26e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.78e-06	2.25e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.77e-06	2.25e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.77e-06	2.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.77e-06	2.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.77e-06	2.25e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.77e-06	2.24e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.77e-06	2.24e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.77e-06	2.24e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.76e-06	2.24e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.76e-06	2.23e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.76e-06	2.23e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.75e-06	2.22e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.74e-06	2.21e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.74e-06	2.21e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.73e-06	2.2e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.72e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.72e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.72e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.72e-06	2.18e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.72e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.72e-06	2.17e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.71e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.71e-06	2.17e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	2.17e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.7e-06	2.15e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.7e-06	2.15e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.69e-06	2.15e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.69e-06	2.14e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.69e-06	2.14e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.69e-06	2.14e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.68e-06	2.14e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.68e-06	2.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.68e-06	2.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.67e-06	2.12e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.67e-06	2.11e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.66e-06	2.11e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.66e-06	2.11e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.66e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.66e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.66e-06	2.1e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.65e-06	2.09e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.64e-06	2.08e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.64e-06	2.07e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	1.64e-06	2.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.63e-06	2.07e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.63e-06	2.07e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.07e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.63e-06	2.07e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.63e-06	2.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	2.06e-05	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.62e-06	2.06e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.62e-06	2.05e-05	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.62e-06	2.05e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	2.04e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.61e-06	2.04e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.61e-06	2.04e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.61e-06	2.04e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.6e-06	2.03e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.6e-06	2.03e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.6e-06	2.03e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.6e-06	2.03e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.6e-06	2.02e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.59e-06	2.02e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.59e-06	2.01e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.58e-06	2e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.57e-06	1.99e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.57e-06	1.99e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.57e-06	1.98e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.56e-06	1.98e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.56e-06	1.97e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.55e-06	1.96e-05	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.55e-06	1.96e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.54e-06	1.95e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-06	1.95e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-06	1.95e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.54e-06	1.95e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.53e-06	1.94e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.53e-06	1.94e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.53e-06	1.94e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.53e-06	1.94e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.52e-06	1.93e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.52e-06	1.93e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.52e-06	1.92e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.51e-06	1.92e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.51e-06	1.92e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.51e-06	1.91e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.5e-06	1.91e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.5e-06	1.9e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	1.9e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.49e-06	1.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.49e-06	1.89e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.49e-06	1.89e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	1.87e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.47e-06	1.87e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.47e-06	1.86e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-06	1.86e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.47e-06	1.86e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-06	1.85e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.45e-06	1.84e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.44e-06	1.82e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.43e-06	1.82e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-06	1.81e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.43e-06	1.81e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.41e-06	1.79e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.41e-06	1.79e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.41e-06	1.79e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.41e-06	1.79e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.4e-06	1.78e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.4e-06	1.78e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-06	1.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.4e-06	1.78e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.4e-06	1.78e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-06	1.77e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-06	1.77e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-06	1.76e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-06	1.76e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.38e-06	1.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-06	1.75e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-06	1.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.38e-06	1.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.37e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.37e-06	1.73e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.36e-06	1.73e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.36e-06	1.73e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.36e-06	1.72e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.36e-06	1.72e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.35e-06	1.71e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.35e-06	1.71e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.34e-06	1.7e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.34e-06	1.7e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.34e-06	1.69e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.34e-06	1.69e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.32e-06	1.68e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.32e-06	1.67e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.31e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.31e-06	1.66e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.3e-06	1.65e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	1.65e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.3e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	1.64e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	1.64e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	1.64e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.29e-06	1.63e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.29e-06	1.63e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.28e-06	1.62e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.28e-06	1.62e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.28e-06	1.62e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.27e-06	1.62e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	1.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.27e-06	1.61e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	1.61e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-06	1.6e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-06	1.6e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-06	1.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.26e-06	1.59e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.25e-06	1.59e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.25e-06	1.59e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.25e-06	1.58e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.25e-06	1.58e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	1.56e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.23e-06	1.56e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-06	1.55e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.21e-06	1.54e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-06	1.53e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-06	1.53e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.2e-06	1.52e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	1.52e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.2e-06	1.51e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	1.51e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	1.51e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	1.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.18e-06	1.5e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	1.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	1.49e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-06	1.49e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-06	1.49e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.17e-06	1.48e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-06	1.47e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-06	1.47e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.16e-06	1.47e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	1.47e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.15e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.15e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.15e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.14e-06	1.45e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.12e-06	1.42e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.1e-06	1.4e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.39e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-06	1.39e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	1.37e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	1.37e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.37e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-06	1.36e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-06	1.35e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	1.35e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	1.35e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-06	1.34e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	1.34e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.05e-06	1.33e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-06	1.32e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-06	1.32e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.03e-06	1.3e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.01e-06	1.28e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.85e-07	1.25e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.83e-07	1.25e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	9.83e-07	1.25e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.66e-07	1.22e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	9.44e-07	1.2e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	9.4e-07	1.19e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.99e-07	1.14e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.99e-07	1.14e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.71e-07	1.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.67e-07	1.1e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.3e-07	1.05e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.29e-07	1.05e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	8.19e-07	1.04e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.16e-07	1.03e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.14e-07	1.03e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.01e-07	1.02e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.99e-07	1.01e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.65e-07	9.69e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.53e-07	9.54e-06	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	7.52e-07	9.53e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.51e-07	9.52e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.42e-07	9.41e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.39e-07	9.37e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.37e-07	9.34e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.85e-07	8.68e-06	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	6.5e-07	8.24e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	5.8e-07	7.35e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.34e-07	6.76e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.29e-07	6.7e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.52e-07	5.73e-06	CbGpPWpGaD
